Study Stopped
Because we don´t have the necessary technology anymore
Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?
MACs-ESD
Embryo Development Measure Depending on the DNA Sperm Fragmentation
Sponsor study identifier
interventional
60
1 country
1
Study Start
February 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2018
Actual (reported)Study Completion
February 2018
Actual (reported)The embryokinetics may be a new prognostic factor for choosing the human embryos with the highest implantation potential. In order to identify the factors that may affect the rate of embryo cleavage, there are many studies about morphokinetics and culture medium, oxygen tension, oocyte quality or type of medication used for ovarian stimulation. However there are no published data with respect to the influence of sperm DNA fragmentation in the embryo kinetic.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 25, 2014
Actual (reported)August 12, 2014
Actual (reported)February 2016
Date type not reportedThis date has not been verified as actual or estimated.
February 2018
Actual (reported)February 2018
Actual (reported)Time of pronuclear appearance in hours.
We want to study whether differences exist in the time of appearance of pronuclei in those embryos that derived from semen samples from the two study groups the minimum value of the difference to be detected; we said that about 3 hours apart.
The mean time of appearance of pronuclei is 3.3951 hours in our patients. We are going to evaluate pronuclear appearence time in hours in our study groups
Patients with MACS Selection
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
IVI Madrid
Madrid, 28023, Spain
Manuela Alonso
IVI Madrid
David Agudo, PhD
IVI Madrid
Maria Testillano
IVI Madrid
Alberto Pacheco, PhD
IVI Madrid
60 participants (actual enrollment reported by the registry).
First Submitted
July 25, 2014
First Posted
August 12, 2014
Study Start
February 2016
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
February 2018
Actual (reported)Study Completion
February 2018
Actual (reported)Last Updated
April 4, 2018
Record last verified: 2018-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: